Peptide TherapeuticsPeer Reviewed
Coadministration of scopolamine and mGlu2 NAM VU6001966 as a novel antidepressant approach: Lowering effective dose and reducing cognitive side effects.
Authors (7)
Yana BabiiDepartment of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
Agnieszka Pałucha-PoniewieraDepartment of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
Bartosz BobulaDepartment of Physiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
Agnieszka KaniaDepartment of Physiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
Psychopharmacology
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
AntidepressantBDNFEEF2MTORScopolamineTrkBUCMSVU6001966
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.